D239baac-figure-01 (Gabapentin 300mg 1)
Gabapentin
Product Images NDC 45865-347
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 45865-347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
D239baac-figure-02 (Gabapentin 300mg 2)
D239baac-figure-03 (Gabapentin 300mg 3)
This is a chart showing the mean pain scores for a study that involved a 3-week dose titration period and a 4-week fixed dose period. The study involved a placebo group and two groups taking different doses of gabapentin (1800 mg/day and 2400 mg/day). The chart shows that both doses of gabapentin resulted in a significant reduction in pain compared to placebo (p<0.001).*
D239baac-figure-04 (Gabapentin 300mg 4)
The provided text shows a chart depicting the percentage of responders at the endpoint for two different studies (Study 1 and Study 2). The chart displays percentages ranging from 2% to 20% with the label "PBEO" placed in the middle. No further information is provided.*
D239baac-figure-05 (Gabapentin 300mg 5)
Bottle Of 30 (Gabapentin 300mg 6)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
